thiophenes has been researched along with cs-2100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Asano, M; Doi, H; Inoue, R; Kagari, T; Kaneko, R; Kawase, Y; Kimura, T; Mizuno, Y; Nagasaki, M; Nakamura, T; Nara, F; Nishi, T; Oguchi-Oshima, K; Sekiguchi, Y; Shimozato, T; Tamaki, K; Tomisato, W; Watanabe, N; Yuita, H | 1 |
| Asano, M; Doi-Komuro, H; Inoue, R; Kagari, T; Kamiyama, E; Kaneko, R; Kawase, Y; Mizuno, Y; Nagasaki, M; Nakai, D; Nakamura, T; Nara, F; Nishi, T; Oguchi-Oshima, K; Sekiguchi, Y; Shimozato, T; Tamaki, K; Tomisato, W; Urasaki-Kaneno, Y; Yabe, Y; Yuita, H | 1 |
2 other study(ies) available for thiophenes and cs-2100
| Article | Year |
|---|---|
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.
Topics: Administration, Oral; Animals; Binding, Competitive; Drug Discovery; Humans; Immune System; Immunosuppressive Agents; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Oxadiazoles; Rats; Receptors, Lysosphingolipid; Structure-Activity Relationship; Thiophenes | 2012 |
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist.
Topics: Administration, Oral; Animals; Chemistry Techniques, Synthetic; Drug Design; Female; Half-Life; Humans; Male; Mice; Oxadiazoles; Rats; Receptors, Lysosphingolipid; Thiophenes | 2012 |